drugset / Trial / NCT03121963

Pain Management in Head and Neck Surgery Patients

NCT03121963

RandomizedParallel-groupSingle-blindTreatment

Summary

Our study aims to see if the addition of a scheduled non-opioid pain regimen will decrease the use and risk of opioid pain medications as well as improve pain control in head and neck surgery patients. Participants will be randomized to one of two pain regimens (opioid medication regimen vs combination regimen of opioid and non-opioid medications).

Timeline

Start
2017-11-10
Primary completion
2020-11-06
Completion
2021-11-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule 650 mg
Subject Celecoxib Other / unclassified 400 mg
Subject Gabapentin Small molecule 300 mg
Comparator Hydrocodone Unknown 5 mg
Comparator Hydrocodone Unknown 7.5 mg
Comparator Hydrocodone Unknown 325 mg
Subject Oxycodone Other / unclassified 5 mg

Indications

No indication recorded.